Atlas Trials

Clinical Study to Investigate the Efficacy and Safety of SJP002 Ophthalmic Solution in Patients With Dry Eye Syndrome.

Clinical trial NCT03723811 · COMPLETED

Trial details

NCT number
NCT03723811
Sponsor
Samjin Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dry Eye Syndromes
Start date
2017-11-28
Primary completion
2018-06-26
Enrollment
152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.